Carla de Abreu Lopes Takes the Helm at Securitas Portugal, Bringing Over 20 Years of Legal Expertise

Lisbon, Portugal — Carla de Abreu Lopes has been appointed the new leader of legal, risk, and compliance at Securitas Portugal, the company announced through its social media platforms. Lopes comes to this role from Huawei Technologies, where she held the position of head of legal for the past three years. Bringing over two decades of legal expertise, Lopes has a solid track record in team leadership and the management of intricate legal processes, according to Securitas. Her previous experience includes serving as legal counsel manager at Samsung Portugal and nearly ten years as an … Read more

Johnson & Johnson Faces Legal Setback as Bankruptcy Court Ruling Reverberates in Talc Litigation

NEW BRUNSWICK, N.J. — A recent ruling in favor of Johnson & Johnson marks a significant turning point in the company’s ongoing legal challenges regarding its talcum powder products. This decision follows a series of contentious bankruptcy proceedings and reflects a broader struggle faced by companies confronting multi-billion-dollar tort claims. After a lengthy legal battle, a New Jersey judge dismissed a lawsuit against the pharmaceutical giant related to allegations that its talc products caused cancers in users. The dismissal emphasizes the complex interplay between bankruptcy law and liability claims in tort cases. Johnson & Johnson … Read more

Trailblazing Legal Team Fights for Justice in Landmark Roundup Case Against Monsanto

SAN FRANCISCO — The ongoing legal battle surrounding Roundup, a weed killer produced by Monsanto, continues to draw attention as plaintiffs claim it causes cancer. This situation has garnered significant national focus, with numerous lawsuits against the company raising concerns about the safety of the herbicide. As the litigation unfolds, many cases involve individuals who allege that prolonged exposure to Roundup has led to their diagnosis of non-Hodgkin lymphoma. A pivotal case in this series, Pilliod v. Monsanto Co., has recently spotlighted the issue, as the court weighed the evidence presented by both sides. The … Read more

Legal Clash: AstraZeneca Fights to Overturn Louisiana’s Controversial 340B Law in Appeals Court

New Orleans, Louisiana — An attorney representing AstraZeneca argued before an appeals court this week for the invalidation of a state law concerning the 340B Drug Pricing Program. This legal dispute highlights a growing concern among pharmaceutical companies regarding the impact of similar legislation across the United States. The attorney contended that the Louisiana law significantly alters how drug pricing is managed, contending that it imposes restrictions that could disrupt the pharmaceutical industry’s operations. The 340B program is designed to enable healthcare providers serving high numbers of low-income patients to purchase drugs at reduced prices. … Read more